Videos

End Price Gouging for Medications Act

I wrote the End Pricing Gouging for Medications Act because we need to stop Big Pharma’s price gouging in its tracks and make sure essential medicine is affordable for everyone in our country. Read more about the End Price Gouging for Medications Act: https://www.merkley.senate.gov/merkley-welch-dingell-crack-down-on-pharmaceutical-greed-introduce-bill-to-end-prescription-drugs-price-gouging/

Senator Merkley Highlights the Need for Climate Action in Hearing – Opening Statement

Senator Merkley highlights the critical importance of investing in climate action and tackling our plastic pollution crisis during a Senate Appropriations Subcommittee on Interior, Environment, and Related Agencies hearing titled, “A Review of the President’s Fiscal Year 2025 Budget Request for the Environmental Protection Agency” on May 1, 2024. Watch

Senator Merkley Drills Down on Big Oil Lies in Budget Committee Hearing

Senator Merkley asks Representative Raskin about Big Oil’s efforts to avoid accountability for its role in climate chaos in a Senate Budget Committee Hearing titled, “Denial, Disinformation, and Doublespeak: Big Oil’s Evolving Efforts to Avoid, Accountability for Climate Change” on May 1, 2024. Watch the full hearing: https://www.budget.senate.gov/hearings/denial-disinformation-and-doublespeak_big-oils-evolving-efforts-to-avoid-accountability-for-climate-change

Senator Merkley Speaks Out Against EPA Nominee Wehrum

Oregon’s Senator Jeff Merkley took to the Senate floor to speak out against the nomination of William Wehrum for a top EPA position. Wehrum has refused to acknowledge the clear human impact on climate disruption and downplayed time and time again the dangers of mercury and power plant emissions.

Senator Merkley Speaks Out Against NLRB Nominee

Oregon’s Senator Jeff Merkley spoke on the Senate floor to urge his colleagues to vote no on National Labor Relations Board (NLRB) General Counsel Nominee Peter Robb, a man who has made a career out of undermining workers’ rights.

en_USEnglish